Sickle-cell Anemia Therapeutics Market in the US 2015-2019
Sickle-cell Anemia Therapeutics Market in the US 2015-2019 Sector Publishing Intelligence Limited (SPi) has been marketing business and market research reports from selected publishers for over five years. SPi offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, SPi is well positioned to coordinate our customers' orders sourced from over 30 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0)1305 753769 or Email: office@sectorpublishing.com 2
Sickle-cell Anemia Therapeutics Market in the US 2015-2019 About Sickle-cell Anemia Sickle-cell anemia is a disease characterized by the presence of sickle-shaped erythrocytes. While normal erythrocytes have a life span of 120 days, sickle-shaped erythrocytes die within 10 to 20 days. The bone marrow is unable to compensate for the excessive loss of erythrocytes, thereby leading to anemia. It is an inheritable disorder passed on across generations. The prevalence of the sickle-cell gene varies between different ethnic groups and geographical locations. TechNavio's analysts forecast the Sickle-cell Anemia Therapeutics market in the US to grow at a CAGR of 17.10 percent over the period 2014-2019. Covered in this Report This report covers the present scenario and the growth prospects of the Sickle-cell Anemia Therapeutics market in the US for the period 2015-2019. To calculate the market size, the report considers the revenue generated through the sales of the US FDA-approved drugs used for the treatment of sickle-cell anemia. TechNavio's report, Sickle-cell Anemia Therapeutics Market in US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It covers the Sickle-cell Anemia Therapeutics market landscape in the US and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key Vendors Bristol-Myers Squibb Future Prominent Vendors Baxter Bluebird Bio Daiichi Sankyo Eli Lilly Emmaus Medical GlycoMimetics HemaQuest Pharmaceuticals Mast Therapeutics Merck Sharp & Dohme Pfizer Selexys Pharmaceuticals Market Driver Unmet Medical Needs For a full, detailed list, view our report Market Challenge Side Effects Associated with Current Therapies For a full, detailed list, view our report Market Trend Increased Focus on Adult Patients For a full, detailed list, view our report Key Questions Answered in this Report What will the market size be in 2019 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? 3
Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors? Additional Details Publisher : TechNavio Reference : IRTNTR5130 Number of Pages : 51 Report Format : PDF Publisher Information : TechNavio, the market research platform of Infiniti Research Ltd, publishes periodic market research reports on niche and emerging technologies. For more information on our Hardware market research, please visit www.technavio.com/hardware 4
Table Of Contents for Sickle-cell Anemia Therapeutics Market in the US 2015-2019 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 03.1 Market Overview 03.2 Product Offering 04. Market Research Methodology 04.1 Market Research Process 04.2 Research Methodology 05. Disease Overview 06. Introduction 07. Market Landscape 07.1 Market Overview 07.2 Market Size and Forecast 07.3 Five Forces Analysis 08. Buying Criteria 09. Market Growth Drivers 10. Drivers and their Impact 11. Market Challenges 12. Impact of Drivers and Challenges 13. Market Trends 14. Trends and their Impact 15. Vendor Landscape 15.1 Competitive Scenario 15.1.1 Key News 15.1.2 Mergers and Acquisitions 15.2 Pipeline Analysis 15.3 Market Share Analysis 2014 16. Future Prominent Vendors 17. Key Vendor Analysis 17.1 Bristol-Myers Squibb 17.1.1 Key Facts 17.1.2 Business Overview 17.1.3 Key Product Offerings 17.1.4 Revenue by Geography 17.1.5 Business Strategy 17.1.6 Key Information 17.1.7 SWOT Analysis 18. Other Reports in this Series List of Exhibits Exhibit 1: Product Offering for Sickle-cell Anemia Therapeutics Market in US Exhibit 2: Market Research Methodology Exhibit 3: Normal erythrocytes and Sickle-shaped Erythrocytes Exhibit 4: Impact of Sickled Erythrocytes on Blood Flow Exhibit 5: Structure of Hemoglobin Exhibit 6: Genetic Basis of Sickle-cell Anemia Exhibit 7: Global Distribution of Sickle-cell Gene 5
Exhibit 8: Symptoms of Sickle-cell Disease Exhibit 9: Inheritance Pattern of Sickle-cell Anemia Exhibit 10: Blood Sample of Sickle-cell Disease Patients Before and After Stem Cell Transplantation Exhibit 11: Laboratory Tests Recommended Before Initiation of Hydroxyurea Therapy Exhibit 12: Facts for Hemoglobin Disorders Exhibit 13: RuSH Project Sites Exhibit 14: PHRESH: Primary Focus Exhibit 15: Sickle-cell Anemia Therapeutics Market in US 2014-2019 (US$ million) Exhibit 16: Life Expectancy of Sickle-cell Disease Patients in US Exhibit 17: Sickle-cell Disease Treatment Demonstration Program Regional Collaborative Technical Assistance: Aims of Funding Exhibit 18: Bristol-Myers Squibb Co.: Key Product Offerings (Based on Therapeutic Areas) Exhibit 19: Bristol-Myers Squibb Co.: Revenue by Geographical Segmentation 2013 6
How to Buy... Sickle-cell Anemia Therapeutics Market in the US 2015-2019 Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and email it to us at office@sectorpublishing.com or Fax it to us at +44 (0)1305 791844.We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Email: Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $2000 Single User Price $2240 Five User License Price $3200 Enterprise License Price $8000 Global License Price Payment Options: (please tick one) Online Credit Card (we will email you the invoice with a payment link) Direct Wire Transfer (we will email you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0)1305 753769 We will be delighted to give you our personal attention. 7